Sarcopenia: Diagnostic precision and radiologic power

Sarcopenia, a progressive loss of muscle mass and strength, is emerging as a major clinical concern amid global demographic shifts and rising chronic disease burdens. Once viewed as a byproduct of aging, it is now recognized as a dynamic, multifactorial syndrome also seen in children with chronic illness and adults with malignancies, metabolic disorders, or prolonged immobility. Its prevalence increases sharply after the age of 70 and is often accompanied by functional decline, frailty, and increased morbidity. Sarcopenic obesity—a condition where fat accumulation coincides with muscle degradation—is also gaining attention due to its association with metabolic and inflammatory diseases, including non-alcoholic fatty liver disease and cardiometabolic risk.

Radiologic tools have revolutionized sarcopenia detection. Dual X-ray absorptiometry (DXA), computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound offer complementary capabilities in assessing muscle volume, quality, and fat infiltration. CT and MRI, though more resource-intensive, allow detailed segmentation and opportunistic use during routine cancer staging. MRI methods like Dixon imaging and spectroscopy provide advanced insights into intramuscular fat content and metabolism. AI-based segmentation and radiomics analysis now offer automated, reproducible, and clinically meaningful evaluations of muscle loss, especially in oncology and intensive care.

Clinically, sarcopenia correlates strongly with negative outcomes in cancer patients, such as shorter survival, higher complication rates, and diminished chemotherapy tolerance. Similarly, in infections and inflammatory conditions like pancreatitis and COVID-19, muscle degradation correlates with prolonged hospitalization and higher mortality. Early identification—supported by routine imaging and AI tools—enables personalized interventions such as resistance training and tailored nutrition, aiming not only to slow the decline but to restore functional independence.

By embedding sarcopenia into radiologic workflows and clinical decision-making, healthcare systems can move from reactive to preventive care models—where body composition is no longer overlooked, but embraced as a vital sign of aging and disease resilience.